Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.

1979/01/01 by Akira Endo, AKIRA ENDO · 5 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Microbial Metabolism and Applications #Morinda citrifolia extract uses #Pharmacological Effects of Natural Compounds

paper · pdf · doi:10.7164/antibiotics.32.852

crossref issued 1979/01/01 · crossref published 1979/01/01 · crossref published-print 1979/01/01 · openalex publication_date 1979/01/01 · crossref created 2012/02/29 · crossref deposited 2012/02/29 · openalex created_date 2025/10/10 · crossref indexed 2026/07/31 · openalex updated_date 2026/08/01

Citations

• ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

Cited by

• Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.
• BIOACTIVE MICROBIAL PRODUCTS: Focus upon Mechanism of Action
• Production of valuable compounds by molds and yeasts
• Monacolin K affects lipid metabolism through SIRT1/AMPK pathway in HepG2 cells
• Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs